Register Now

Overview

Is the basic panel enough? This case-based session explores when to order further lipid labs, laboratory testing for liver fibrosis; the role of cystatin C and urine albumin testing for kidney disease; blood-based biomarker testing for Alzheimer’s disease, type 1 diabetes and antibody testing; and multi-cancer early detection options available to primary care clinicians.

Learning Objectives

  • Recognize patients whose “normal” or “mildly elevated” basic panel may be hiding unrecognized risk for disease progression, morbidity and mortality
  • Summarize newer laboratory testing that is available to primary care clinicians and how to implement based on the newest guideline updates
  • Discuss pitfalls, limitations and how to interpret abnormal results